Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

December 30, 2023 4:16 (London Time)

Illumina

Youtube Subscribe

...

Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9922
MarketCap: 22,117,664,000.0
High: 142.76 Low: 138.5

Open: 141.22 Close: 139.24 Change: -1.98

The best way to get information about Illumina Company Inc Stock: Use an AI.

This document will help you to evaluate Illumina without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, investor, security, Inc, stock, price, loss, and the …

Concept Map

...

Semantic Network

...

Stock Summary

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. The company offers sequencing and array-based instruments and consumables, which include reagents, flow.

Today's Summary

Illumina Inc. stock underperforms thursday when compared to competitors - marketwatch.com. ILMN -2.03% SPX -0.28% DJIA - 0.05% LH +0.10% CRL -1.00% DGX +0.

Today's News

Illumina, Inc. (ILMN) stock price, quote & news - stock analysis. It operates through Core Illumina and GRAIL segments. Illumina Inc. stock underperforms thursday when compared to competitors - marketwatch.com. ILMN -2.03% SPX -0.28% DJIA - 0.05% LH +0.10% CRL -1.00% DGX +0. Illumina investors have suffered significant losses as a result of materially misleading statements and omissions to the public. The action charges Illumina with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects. CLICK HERE  TO SUBMIT YOUR ILLUMINA LOSSES. The boroker Developed a virus callde “Brokcer coing enereterer” which also infected my computer Illumina iis depressed and sounds like gabriel from ultrerkill. Illumina Korea Hi Investment & Securities building 66 Yeoidaero Yeoungdeungpo-gu Seoul Korea 07325 02-740-5300 (tel) 02-786-8368. Illumina Korea Hi Investment & Securities building 66 Yeoidaero Yeoungdeungpo-gu Seoul Korea 07325 02-740-5300 (tel) 02-786-8368 (fax) customercare@illumina.com. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research. Illumina investors have suffered significant losses as a result of Illuminas materially misleading statements and omissions to the public. The action charges Illumina with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects. CLICK HERE  TO SUBMIT YOUR ILLUMINA LOSSES. Investors have opportunity to lead Illumina, Inc. securities fraud lawsuit. Zacks Consensus Estimate for Illuminas 2023 earnings has been constant at $1.73. Illumina investors may, no later than January 9, 2024, move the Court to serve as lead plaintiff for the class, through Kessler Topaz Meltzer & Check. Levi & Korsinsky, LLP notifies investors in Illumina, Inc. of a class action securities lawsuit. The lawsuit seeks to recover losses on behalf of Illumina investors who were adversely affected by alleged securities fraud between May 1, 2023 and October 16, 20 23. Illumina investor deadline approaching: securities litigation partner james (josh) wilson encourages investors who suffered losses exceeding $100,000 in Illumina to contact him directly to discuss their options. On August 10, 2023, after the market closed, Illumina revealed that the SEC was investigating the statements regarding its recent acquisition of cancer diagnostic test maker Grail. On this news, the Companys stock price. fell 7%, during ongoing Case Socict graphmons int │Exceptandro charges Illumina forced to divest grail, while investor class action now alleges an expanded fraudulent period – hagens berman.com/investor-fraud/ILMN. Illumina CEO Francis deSouza on Genomics, CRISPR, and the future. Illumina Stranded mRNA Prep is a simple, scalable, cost-effective, rapid single-day solution. Illumina, Inc. (NASDAQ:ILMN) seems to be fairly priced at around 11% below our intrinsic value, which means if you buy Illumina today, youd be paying a reasonable price for it. With profit expected to grow by 97% over the next couple of years, the future seems bright.

Stock Profile

"Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California."

Keywords

Are looking for the most relevant information about Illumina? Investor spend a lot of time searching for information to make investment decisions in Illumina. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, investor, security, Inc, stock, price, loss, and the most common words in the summary are: illumina, sequence, learn, clinical, genomics, 및, news, . One of the sentences in the summary was: Illumina Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #illumina #sequence #learn #clinical #genomics #및 #news.

Read more →

Related Results

...
March 14, 2024 15:18 (London Time)

Illumina

Carl Icahn has decided not to launch a fresh proxy fight at DNA sequencing company Illumina Inc. Icahn said on Monday that he plans to oust director…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.5684
MarketCap: 21,098,742,000.0
High: 133.2 Low: 129.95

Open: 131.94 Close: 130.09 Change: -1.85

Read more →
...
December 30, 2023 4:16 (London Time)

Illumina

Illumina Inc. stock underperforms thursday when compared to competitors - marketwatch.com. ILMN -2.03% SPX -0.28% DJIA - 0.05% LH +0.10% CRL -1.00% …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9922
MarketCap: 22,117,664,000.0
High: 142.76 Low: 138.5

Open: 141.22 Close: 139.24 Change: -1.98

Read more →
...
December 17, 2023 17:42 (London Time)

Illumina

Illumina announced Monday it filed a draft registration statement with the U.S. Fifth Circuit Court of Appeals. Court sides with ftc finding Illumin…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.8412
MarketCap: 20,183,480,000.0
High: 134.34 Low: 126.82

Open: 133.71 Close: 127.1 Change: -6.61

Read more →
...
December 06, 2023 1:49 (London Time)

Illumina

Illumina inc. stock outperforms market on strong trading day. Company size 5,001-10,000 employees. Illumina provides array-based solutions for DNA, …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9011
MarketCap: 18,157,192,000.0
High: 114.86 Low: 110.77

Open: 113.07 Close: 111.76 Change: -1.31

Read more →
...
October 15, 2023 19:45 (London Time)

Illumina

EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer screening company Grail. EU antitrust regulators on Thursday ordered Illu…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.8345
MarketCap: 20,430,198,000.0
High: 130.34 Low: 127.58

Open: 129.65 Close: 129.11 Change: -0.54

Read more →
...
June 17, 2023 14:51 (London Time)

Illumina

Francis deSouza steps down as CEO of Illumina amid a bruising battle with regulators to acquire Grail, the cancer blood test startup. Activist inves…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9859
MarketCap: 32,548,047,000.0
High: 212.49 Low: 205.0

Open: 212.1 Close: 205.87 Change: -6.23

Read more →
...
May 22, 2023 14:09 (London Time)

Illumina

Carl Icahn launched a proxy battle against Illumina last month. Icahn concedes Illumina is a “great company,” even though he is. Illumina trades at …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.8016
MarketCap: 34,564,469,952.0
High: 209.15 Low: 205.03

Open: 201.93 Close: 207.31 Change: 5.38

Read more →
...
May 04, 2023 1:51 (London Time)

Illumina

Carl Icahn calls Illumina Q1 results ‘very disappointing, slams cost-cutting plan. Icahn is engaged in a proxy contest with the DNA sequencing firm.…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9881
MarketCap: 31,063,539,712
High: 201.65 Low: 195.25

Open: 195.96 Close: 196.54 Change: 0.58

Read more →
...
January 21, 2024 13:01 (London Time)

Illumina

Illumina (NASDAQ:ILMN) had a negative net margin of 25.20% and a positive return on equity of 2.13% The average price target for Illumina is $142.72…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.705
MarketCap: 21,577,744,000.0
High: 136.75 Low: 132.55

Open: 134.0 Close: 135.88 Change: 1.88

Read more →
...
December 21, 2023 1:54 (London Time)

Illumina

Illumina hopes to finalize divestiture terms by the end of the second quarter of 2024. Activist investor Carl Icahn waged a proxy battle with Illumi…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9423
MarketCap: 22,165,304,000.0
High: 143.74 Low: 136.8

Open: 139.0 Close: 136.9 Change: -2.1

Read more →
...
December 08, 2023 21:55 (London Time)

Illumina

Illumina stock price fell $4.64 - or 5.6%, to close at $124 per share on October 18,23. Carl Icahn filed a complaint alleging direct and derivative …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.8807
MarketCap: 18,600,244,000.0
High: 117.52 Low: 112.9

Open: 116.22 Close: 112.94 Change: -3.28

Read more →
...
November 04, 2023 5:39 (London Time)

Illumina

Portnoy Law Firm advises Illumina, Inc. (NASDAQ:ILMN) investors that the firm has initiated an investigation into possible securities violations.
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.743
MarketCap: 17,770,758,000.0
High: 118.38 Low: 114.96

Open: 114.96 Close: 116.92 Change: 1.96

Read more →
...
August 15, 2023 4:01 (London Time)

Illumina

Illumina reported flat year-over-year second-quarter revenues, lowered 2023 revenue and earnings per share guidance. Firm was fined 432 million euro…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.7788
MarketCap: 28,569,984,000.0
High: 179.44 Low: 174.35

Open: 178.31 Close: 175.14 Change: -3.17

Read more →
...
June 09, 2023 16:41 (London Time)

Illumina

Illumina CEO survived a challenge to his board seat from activist investor Carl Icahn last week. Icahn mustered enough shareholder support to oust b…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.0397
MarketCap: 32,050,032,000.0
High: 202.4 Low: 199.62

Open: 201.67 Close: 200.49 Change: -1.18

Read more →
...
May 14, 2023 16:13 (London Time)

Illumina

Illumina shareholders are up 6.6% this past week, but still in the red over the red. Shares of Illumina jumped as much as 7.2% in Wednesday morning …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.9955
MarketCap: 34,564,469,952.0
High: 211.61 Low: 206.76

Open: 209.34 Close: 208.6 Change: -0.74

Read more →